Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
SBR-Author’s Podcast: Bribery Beyond Borders: The Hidden History and Future of the FCPA with Severin Wirz
'Urgent National Action to Save College Sports': Trump’s NIL Playbook — Highway to NIL Podcast
March Madness or Trademark Madness? The NCAA v. DraftKings Lawsuit
Protecting Your Products and Brand Online
Lemon Pound Cake and the First Amendment
Episode 402: Paul Allen: The Promise of AI, Governance and Public Trust
In today’s digital economy, where brand identity is both a strategic asset and a frequent target of infringement, artificial intelligence (AI) is rapidly becoming indispensable in trademark enforcement. Serving as both sword...more
In our Case of the Week, the Federal Circuit affirmed a judgment that Mylan’s proposed generic hypertension drug would not infringe patents covering Actelion’s Veletri® medication....more
The recent debate over artificial intelligence and inventorship has often focused on a single question: can an AI system such as ChatGPT, DABUS, or another generative model be named as an inventor on a United States patent...more
Startup technology companies often hear—sometimes vaguely, sometimes urgently—that they “need a patent opinion” before launching a product, raising money, or entering the market....more
A federal jury in the U.S. District Court for the District of Massachusetts returned a verdict today (May 19, 2026) against Takeda Pharmaceutical Company in antitrust litigation concerning its branded constipation drug...more
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementation Measures for Drug Trial Data Protection (the “Measures”), effective immediately,...more
Last week in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc., the Federal Circuit delivered generic drug maker Mylan Pharmaceuticals Inc. with a notable victory when it affirmed the district court’s judgment that...more
On May 6, 2026, the Director of the U.S. Patent and Trademark Office issued bulk order institution decisions in two inter partes review (“IPR”) proceedings filed by Sarepta Therapeutics, Inc. against Genzyme relating to...more
With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing EPR patent owners to submit a new...more
Last year, in response to Recentive Analytics, Inc. v. Fox Corp. , we argued that the preemption doctrine should be reinstated as the central inquiry in any 101 subject matter eligibility determination. In Recentive, the...more
In some of our previous episodes, we’ve explored the interesting paths that Wolf Greenfield attorneys have taken as they eventually made their way to IP law. One thing that separates Wolf Greenfield from other firms is the...more
Why Government Contracts Law Is Broader Than It Appears - One of the things I like about government contracts work is its breadth. A single contract may implicate intellectual property, cybersecurity, export controls,...more
Intellectual property shapes how businesses develop new products, protect their brands, and compete in crowded markets. Every April 26, World Intellectual Property Day celebrates the power of human creativity and this year’s...more
Key Takeaways - The Federal Circuit held that an ANDA product formulation did not infringe, literally or under the doctrine of equivalents, patent claims that require lyophilized pharmaceutical compositions of epoprostenol...more
On May 14, 2026, USPTO Director John Squires issued—and designated precedential—a Director decision denying institution of an inter partes review (IPR) in Magnolia Medical Technologies, Inc. v. Kurin, Inc., IPR2026-00097,...more
Kilpatrick Partners Laura Miller and Ty Lord and Hanesbrand’s Harris Henderson (Vice President, Deputy General Counsel) recently spoke at the Association of Corporate Counsel (ACC) Charlotte Chapter on the topic of “Mad Men,...more
The federal Defend Trade Secrets Act of 2016 (DTSA) authorizes civil claims for trade secret misappropriation. DTSA trials are complex, often combining federal claims with state trade secret claims, breach of contract and...more
In In re Lucien G. Lallouz, the Trademark Trial and Appeals Board (the “Board”) was asked to decide whether there would be a likelihood of confusion between CASA BLANCA for distilled spirits and CASABLANCA for wine. Somewhat...more
Assets are not always physical. Many of the most valuable assets a company possesses are intangible, including ideas, proprietary processes, and data. In the construction industry, one of the most important of these assets is...more
eVTOL aircraft are moving toward real-world deployment, but certification remains a critical hurdle alongside early operational programs like the FAA’s eIPP. As companies advance in parallel, careful coordination of...more
Introduction - As artificial intelligence (AI) technology advances, and companies invest hundreds of millions of dollars to stay ahead of the competition, the strategies for protecting the related IP have received...more
On May 14, 2026, USPTO (“Office”) Director John Squires issued a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc. Director Squires denied institution of an inter partes review (IPR) petition where...more
The U.S. Department of Commerce (Commerce), Bureau of Industry and Security (BIS), has issued a Federal Register notice (the Notice) describing procedures for companies that manufacture pharmaceutical products to apply for...more
The rapid adoption of artificial intelligence (AI) across industries has introduced a new set of legal and strategic questions for parties on both sides of commercial and intellectual property license agreements. Whether you...more
In my last post, I wrote about the importance of asking the right question because the answer you get is only as good as the question you ask. That idea is practically universal, it also shows up in how patent eligibility...more